Vertex Pharmaceuticals Incorporated Share Price

Vertex Pharmaceuticals Inc. is a global biotechnology company headquartered in Boston, Massachusetts, specializing in the discovery and development of innovative therapies for serious diseases. Founded in 1989, Vertex became a pioneer in rational drug design and gained prominence for its breakthrough treatments for cystic fibrosis (CF). Its CF medications, including Trikafta, Symdeko, Orkambi, and Kalydeco, have revolutionized care for thousands of patients worldwide, targeting the genetic root cause of the disease. Vertex continues to expand its research pipeline into other critical areas such as sickle cell disease, beta-thalassemia, type 1 diabetes, and pain management, often leveraging cutting-edge genetic and cell-based therapies. The company actively collaborates with partners like CRISPR Therapeutics to harness gene-editing technologies. With a focus on high-impact science and a mission to transform lives, Vertex remains at the forefront of biotech innovation, driving forward treatments that were once considered impossible.